Fig. 1From: A potential link between fibroblast growth factor-23 and the progression of AKI to CKDSerum FGF-23 levels in AKI patients. (a) Serum FGF-23 levels in AKI patients and healthy controls. (b) Serum FGF-23 levels of AKI patients in the CKD progression group and non-CKD progression group. non-CKD-P: non-CKD progression. CKD-p: CKD progression. (*P < 0.05; **P < 0.01)Back to article page